0 NASDAQ Companies - May 8, 2024Chris McDermott Joins Meridian Bank as SVP, Commercial LendingMALVERN, Pa., May 08, 2024 (GLOBE NEWSWIRE) — Meridian Bank announced the appointment of Christopher E. McDermott to the position […]Read More
0 NASDAQ Companies - May 8, 2024Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and DevelopmentDUBLIN, Ireland, May 08, 2024 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on […]Read More
0 NASDAQ Companies - May 8, 2024Cumulus Media Names Mike Eaby Vice President/Executive Producer of Westwood One SportsATLANTA, May 08, 2024 (GLOBE NEWSWIRE) — Cumulus Media (NASDAQ: CMLS) today announced Mike Eaby’s promotion to Vice President/Executive Producer […]Read More
0 NASDAQ Companies - May 8, 2024Jet.AI Announces the Launch of its National Jet Card ProgramLAS VEGAS, May 08, 2024 (GLOBE NEWSWIRE) — Jet.AI Inc. (“Jet.AI” or the “Company”) (NASDAQ: JTAI), an innovative private aviation […]Read More
0 NASDAQ Companies - May 8, 2024First Merchants Corporation Announces Retirement of Board Chair Charles E. Schalliol and Appointment of New Board Chair Jean L. WojtowiczMUNCIE, Ind., May 08, 2024 (GLOBE NEWSWIRE) — First Merchants Corporation announced that Jean L. Wojtowicz has been appointed as […]Read More
0 NASDAQ Companies - May 8, 2024UPDATE – iCAD to Report First Quarter 2024 Financial Results on May 15, 2024NASHUA, N.H., May 08, 2024 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer […]Read More
0 NASDAQ Companies - May 8, 2024Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory BoardCAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) — Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a preclinical-stage biopharmaceutical […]Read More
0 NASDAQ Companies - May 8, 2024LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activation in Cancer”Recent Findings Relate to LIXTE’s Lead Clinical Compound, LB-100, to be Presented at Workshop on May 9 and 10 at […]Read More
0 NASDAQ Companies - May 8, 2024Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial ResultsBERKELEY HEIGHTS, N.J., May 08, 2024 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), […]Read More
0 NASDAQ Companies - May 8, 2024WalkMe Announces Date of First Quarter 2024 Financial Results and Conference CallSAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) — WalkMe Ltd. (NASDAQ: WKME), a leading provider of digital adoption solutions, today […]Read More